IP Library Granted Patent US 6,942,874
Granted Patent B2
US 6,942,874 · App. 09/865,346 · Granted Sep 13, 2005

Nucleotide compounds that block the bitter taste of oral compositions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,942,874
App. No.
09/865,346
Granted
Sep 13, 2005
Kind
B2
Abstract

Nucleotides that block the bitter taste of foods, beverages, pharmaceutically active oral dose preparations, cosmetics and other bitter compounds that come into contact with taste tissue. The nucleotides consist of a purine or pyrimidine group, or derivative thereof, and an ionizable phosphate or other anionic organic molecule.

Claims (9)

1. A composition comprising a bitter tastant selected from the group comprising foods and beverages, and a bitterness inhibitor, wherein said bitterness inhibitor is uridine 5′-monophosphate and the inhibitor is present at a concentration which inhibits bitterness.

2. A composition comprising a bitter tastant selected from the group comprising foods and beverages, and a bitterness inhibitor, wherein said bitterness inhibitor is a purine or pyrimidine group, or derivative thereof, and ionizable phosphate or other anionic organic molecule and the inhibitor is present at a concentration which inhibits bitterness.

3. A method of inhibiting the perception of a bitter taste of a food or beverage in a subject comprising administering to the subject an effective amount of a bitterness inhibitor wherein said inhibitor is uridine 5′-monophosphate.

4. A method of inhibiting the perception of a bitter taste of a food or beverage in a subject comprising administering to the subject an effective amount of a bitterness inhibitor wherein said inhibitor is a purine or pyrimidine group, or derivative thereof, and ionizable phosphate or other anionic organic molecule.

5. A composition consisting essentially of a bitter tastant selected from the group comprising foods and beverages, and a bitterness inhibitor, wherein said bitterness inhibitor is uridine 5′-monophosphate and the inhibitor is present at a concentration which inhibits bitterness.

6. A method of inhibiting the perception of a bitter taste of a food or beverage in a subject, said method consisting essentially of administering to the subject an effective amount of a bitterness inhibitor in a composition which consisting essentially of a bitter tastant and bitterness inhibitor wherein said inhibitor is uridine 5′-monophosphate.

7. A method of inhibiting the perception of a bitter taste of a food or beverage in a subject consisting essentially of administering to the subject an effective amount of a bitterness inhibitor in a composition which consists essentially of a bitter tastant and bitterness inhibitor wherein said inhibitor is a purine or pyrimidine group, or derivative thereof, and ionizable phosphate or other anionic organic molecule.

8. The composition of claim 1 , wherein said bitter tastant consists essentially of a bitter food, wherein said bitterness inhibitor is uridine 5′-monophosphate and the inhibitor is present at a concentration which inhibits bitterness.

9. The composition of claim 1 , wherein said bitter tastant consists essentially of a bitter beverage, wherein said bitterness inhibitor is uridine 5′-monophosphate and the inhibitor is present at a concentration which inhibits bitterness.

Assignments (3)
CHANGE OF NAME Recorded Mar 8, 2007
From: LINGUAGEN CORP.
To: REDPOINT BIO CORPORATION
Reel/Frame 018972/0759 →
SECURITY AGREEMENT Recorded Jun 15, 2006
From: LINGUAGEN CORP.
To: NJTC VENTURE FUND SBIC, L.P.
Reel/Frame 017794/0931 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 5, 2002
From: MCGREGOR, RICHARD ALEXANDER; GRAVINA, STEPHEN ANTHONY
To: LINUAGEN CORP.
Reel/Frame 012959/0610 →